CD276 and glioblastoma: The results obtained showed that CD276 could positively regulate GBM cell proliferation, invasion, migration, angiogenesis, epithelial-mesenchymal transition (EMT), apoptosis and inflammation, whereas it negatively regulated GBM cell DNA damage and repair, cell cycle and tumor cell stemness (Fig. 15A-C).